Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
企業コードSRDX
会社名Surmodics Inc
上場日Mar 04, 1998
最高経営責任者「CEO」Hance (Robert B)
従業員数389
証券種類Ordinary Share
決算期末Mar 04
本社所在地9924 West 74th Street
都市EDEN PRAIRIE
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号55344
電話番号19525007000
ウェブサイトhttps://www.surmodics.com/
企業コードSRDX
上場日Mar 04, 1998
最高経営責任者「CEO」Hance (Robert B)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし